Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC extends comment period

This article was originally published in The Tan Sheet

Executive Summary

FTC grants a 90-day extension of the March 19 deadline for comments related to the commission's Guides Concerning the Use of Endorsements and Testimonials in Advertising and two consumer surveys it commissioned. The Electronic Retailing Association said it needs more time to evaluate the two reports and compile member opinions on the subject, FTC states. The new deadline for comments is June 18, according to FTC. The commission published the results of the two commissioned studies on efficacy of testimonial ads' disclosure statements in January. The studies found dietary supplements' disclosure statements are largely ineffective in helping consumers understand efficacy claims communicated in a testimonial advertisement (1"The Tan Sheet" Jan. 22, 2007, p. 10)....

You may also be interested in...



Disclosure Statements In Testimonial Ads Largely Ineffective – FTC Studies

Results from two studies funded by the Federal Trade Commission show disclosure statements for dietary supplements are largely ineffective in helping consumers understand product efficacy claims after they view testimonial advertisements

Pfizer’s Pegfilgrastim Biosimilar ‘Has Launched’ In The US

Pfizer has pressed on with the launch of a fourth biosimilar pegfilgrastim product, Nyvepria (pegfilgrastim-apgf), according to an investment bank. With Amgen continuing to hold more than 70% of the market, there is opportunity for Pfizer to capture significant market share.

EU Business Round-Up: Galenica Boosted By Deals, Alliance's Sales Rise, And Beiersdorf Relaunches Wound Care

Latest EU business news: Galenica posts sales up in 2020 thanks to deals; Alliance Pharma's Consumer sales edge up despite COVID-19; and Beiersdorf is relaunching its wound care range with sustainability in mind.

Topics

UsernamePublicRestriction

Register

OM011381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel